-
Economic Evaluation of a Booster Dose of TDaP Vaccine to Adolescents in Spain
Sep 9, 2025, 16:22 PM -
Effective Use of Reconstructed Survival Data for Individual-Level Correlation Assessment in Oncology: A Case Study in Metastatic-Hormone Sensitive Prostate Cancer (mHSPC)
Sep 9, 2025, 16:22 PM -
Development of an Indicator-Based Framework for Epidemic Phase Classification in Emerging Respiratory Infectious Diseases
Sep 9, 2025, 16:22 PM -
Potential Operational Efficiencies of a Combination Influenza and COVID-19 Vaccine in US Pharmacies
Sep 9, 2025, 16:22 PM -
Bimekizumab Led to Sustained Improvements in Health-Related Quality of Life and Work Productivity in Patients With Axial Spondyloarthritis: 3-Year Results From Two Phase 3 Studies
Sep 9, 2025, 16:22 PM -
Pharmacist-Led Education Improves Inhaler Satisfaction Adherence and Asthma Control in Asthma Patients
Sep 9, 2025, 16:22 PM -
Role of Real-World Evidence (RWE) in Pricing and Reimbursement Decisions for Rare Disease in Health Technology Assessment (HTA) Submissions Across EU4 + UK
Sep 9, 2025, 16:22 PM -
Assessing the Economic Impact of a Robotic-Assisted Solution vs. a Manual Approach in Total Knee Arthroplasty in the UK
Sep 9, 2025, 16:22 PM -
Regulatory Landscape Challenges and Trends in the Adoption of Digital Endpoints in Clinical Trials: A Scoping Review
Sep 9, 2025, 16:22 PM -
Treatment Patterns of Rare Immunodeficiencies With Special Regard to Antibiotics: A German Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Systematic Literature Review and Bayesian Network Meta-Analysis of Sugemalimab Plus Chemotherapy vs. Other First-Line Treatments for Metastatic Non-Small Cell Lung Cancer Without Sensitizing eGFR, ALK, ROS1, or RET Alterations
Sep 9, 2025, 16:22 PM -
Paying for Advanced Therapy Medicinal Products: Are Spreading Payments Over Time the Solution?
Sep 9, 2025, 16:22 PM -
Budget Impact of Introducing an Omalizumab Biosimilar in 23 European Countries
Sep 9, 2025, 16:22 PM -
The Reliability and Validity of the Greek Version of the Pediatric Quality of Life Inventory™ 30 Duchenne Muscular Dystrophy Module in Children With Duchenne Muscular Dystrophy
Sep 9, 2025, 16:22 PM -
Identification of Real-World Data to Study HAE Unmet Need: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Bimekizumab Budget Impact Analysis for the Treatment of Patients With Moderate-to-Severe Hidradenitis Suppurativa (HS) in Greece
Sep 9, 2025, 16:22 PM -
Bridging Systemic Access Gaps for Cancer Medicines: A Policy Perspective From the Republic of Moldova
Sep 9, 2025, 16:22 PM -
Science at PACE? A Multi-Stakeholder Developed Framework for Accelerated Patient Access to Cancer Care
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of Targeted-Release Form (TRF)-Budesonide for the Treatment of Adult Population With Immunoglobulin A Nephropathy (IgAN) in Greece
Sep 9, 2025, 16:22 PM -
Targeted Literature Review Informing Economic Model Structures in Atherosclerotic Cardiovascular Disease
Sep 9, 2025, 16:22 PM
